- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 317/68 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 317/68
Total number of patents in this class: 96
10-year publication summary
|
7
|
14
|
3
|
10
|
6
|
8
|
6
|
4
|
1
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| VALO Health, Inc. | 193 |
6 |
| Firmenich Incorporated | 161 |
5 |
| Xwpharma Ltd. | 65 |
5 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2339 |
3 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3035 |
3 |
| Vertex Pharmaceuticals Incorporated | 1589 |
2 |
| AbbVie S.á.r.l. | 27 |
2 |
| Emory University | 1740 |
2 |
| The Florida International University Board of Trustees | 690 |
2 |
| Galapagos NV | 215 |
2 |
| Georgetown University | 639 |
2 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 188 |
2 |
| Intrexon Corporation | 95 |
2 |
| Ligand Pharmaceuticals Incorporated | 168 |
2 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 886 |
2 |
| Sunshine Lake Pharma Co., Ltd. | 634 |
2 |
| Anthea Aromatics Private Limited | 11 |
2 |
| SyneuRx International (Taiwan) Corp. | 35 |
2 |
| Calico Life Sciences LLC | 122 |
2 |
| Novartis AG | 10162 |
1 |
| Other owners | 45 |